The Effect of Local Cold Application on Hypertension
1 other identifier
interventional
72
1 country
1
Brief Summary
This study will be conducted to evaluate the effect of local cold application to the nape of the neck on systolic blood pressure, diastolic blood pressure, heart rate, heart rate pressure and headache.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Aug 2021
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 4, 2021
CompletedFirst Posted
Study publicly available on registry
August 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedAugust 10, 2021
August 1, 2021
7 months
August 4, 2021
August 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure
Lowering blood pressure
90 minute
Study Arms (3)
Experimental group
EXPERIMENTALAfter routine drug treatment is given to hypertension patients, the cold gel pack will be applied to the nape for 3 minutes.
Placebo group
PLACEBO COMPARATORAfter routine drug therapy is given to hypertension patients, the gel pack kept at room temperature will be applied to the nape for 3 minutes.
Control group
NO INTERVENTIONRoutine drug treatment will be given to hypertension patients and no application will be made.
Interventions
The cold gel pack will be applied to the nape.
Eligibility Criteria
You may qualify if:
- mg sublingual ACE inhibitor given as a treatment protocol,
- No wound on the nape,
- Does not develop cold intolerance,
- Not taking any hypertension medication and pain medication in the last 6 hours,
- Without heart diseases, peripheral arterial circulation disorders, sensory disorders and edema,
- Not pregnant,
- Agreeing to participate in the study,
- Essential hypertension patients with systolic blood pressure 160 - 179 mmHg, diastolic blood pressure 100 - 109 mmHg.
You may not qualify if:
- Developing cold intolerance,
- Changes in the treatment regimen,
- Panic attack, allergic reaction and any similar situation develops,
- Those who want to withdraw from the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ataturk Universitylead
- Yuzuncu Yil Universitycollaborator
Study Sites (1)
Van Yüzüncü Yıl University Dursun Odabaş Medical Centre Emergency Service
Van, 65080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YAVUZ ÜREN, PhD Student
Ataturk University
- STUDY CHAIR
EMİNE KIYAK, Prof.Dr.
Ataturk University
- STUDY CHAIR
SEVDEGÜL BİLVANİSİ, Prof.Dr.
Yuzuncu Yil University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
August 4, 2021
First Posted
August 10, 2021
Study Start
August 1, 2021
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
August 10, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share